Manufacturing News and Research

RSS
UC-MSC infusions reduce risk of death, quicken recovery time in severe COVID-19 cases

UC-MSC infusions reduce risk of death, quicken recovery time in severe COVID-19 cases

P2 COVID-19 study shows no material safety differences between opaganib and control arms

P2 COVID-19 study shows no material safety differences between opaganib and control arms

Phase 3 trial of Novavax COVID-19 vaccine candidate begins enrolling volunteers

Phase 3 trial of Novavax COVID-19 vaccine candidate begins enrolling volunteers

Many lighter smokers can be addicted to cigarettes

Many lighter smokers can be addicted to cigarettes

Phase 2/3 COVID-19 study evaluates safety, potential identification of preliminary efficacy signals

Phase 2/3 COVID-19 study evaluates safety, potential identification of preliminary efficacy signals

FDA issues warning letters to companies illegally selling unapproved CBD products

FDA issues warning letters to companies illegally selling unapproved CBD products

Cadmium linked to more severe flu and pneumonia infections

Cadmium linked to more severe flu and pneumonia infections

Many US health experts underestimated the coronavirus … until it was too late

Many US health experts underestimated the coronavirus … until it was too late

FDA issues first emergency use authorization for second COVID-19 vaccine

FDA issues first emergency use authorization for second COVID-19 vaccine

Novel SARS-CoV-2 neutralizing antibody enters Phase 1/2a clinical study

Novel SARS-CoV-2 neutralizing antibody enters Phase 1/2a clinical study

Study: At least a fifth of the world’s population may not have access to covid-19 vaccine until 2022

Study: At least a fifth of the world’s population may not have access to covid-19 vaccine until 2022

Thermo Fisher announces construction of new cGMP plasmid DNA manufacturing facility

Thermo Fisher announces construction of new cGMP plasmid DNA manufacturing facility

University of Ottawa earns 10 Canada research chairs covering a broad scope of subjects

University of Ottawa earns 10 Canada research chairs covering a broad scope of subjects

Vi-DT typhoid conjugate vaccine met primary endpoints in phase III study

Vi-DT typhoid conjugate vaccine met primary endpoints in phase III study

FDA grants EUA for new COVID-19 viral antigen test

FDA grants EUA for new COVID-19 viral antigen test

NET study: New theranostic approach effective in reducing tumor volume and extending lifespan

NET study: New theranostic approach effective in reducing tumor volume and extending lifespan

FDA issues new emergency use authorization for BinaxNOW COVID-19 Ag Card Home Test

FDA issues new emergency use authorization for BinaxNOW COVID-19 Ag Card Home Test

BAT advances COVID-19 vaccine candidate into phase-I clinical trial

BAT advances COVID-19 vaccine candidate into phase-I clinical trial

Researchers use aroma diffuser for assessing the fit of face masks

Researchers use aroma diffuser for assessing the fit of face masks

RedHill Biopharma announces promising preliminary results from opaganib study

RedHill Biopharma announces promising preliminary results from opaganib study

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.